Upstream Bio Inc (NASDAQ:UPB)’s traded shares stood at 0.43 million during the last session. At the close of trading, the stock’s price was $7.92, to imply a decrease of -7.15% or -$0.61 in intraday trading. The UPB share’s 52-week high remains $29.46, putting it -271.97% down since that peak but still an impressive -4.8% since price per share fell to its 52-week low of $8.30. The company has a valuation of $424.49M, with an average of 0.26 million shares in intraday trading volume over the past 10 days and average of 317.23K shares over the past 3 months.
Upstream Bio Inc (NASDAQ:UPB) trade information
After registering a -7.15% downside in the last session, Upstream Bio Inc (UPB) has traded red over the past five days. The 5-day price performance for the stock is -26.46%, and -51.02% over 30 days. With these gigs, the year-to-date price performance is -51.82%. Short interest in Upstream Bio Inc (NASDAQ:UPB) saw shorts transact 2.39 million shares and set a 5.04 days time to cover.
The extremes give us $75 and $75 for target low and target high price respectively. As such, UPB has been trading -846.97% off suggested target high and -846.97% from its likely low.
Revenue forecast for the current quarter as set by 4 analysts is 397.25k. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 400k.
UPB Dividends
Upstream Bio Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Fidelity Small Cap Growth Fund and Fidelity Select Portfolios – Health Care as the top two Mutual Funds with the largest holdings of the Upstream Bio Inc (UPB) shares. Going by data provided on Oct 31, 2024 , Fidelity Small Cap Growth Fund holds roughly 920.21 shares. This is just over 1.72% of the total shares, with a market valuation of $7.29 million. Data from the same date shows that the other fund manager holds a little less at 853.67, or 1.59% of the shares, all valued at about 6.76 million.
